Cargando…

Zinc Overload Enhances APP Cleavage and Aβ Deposition in the Alzheimer Mouse Brain

BACKGROUND: Abnormal zinc homeostasis is involved in β-amyloid (Aβ) plaque formation and, therefore, the zinc load is a contributing factor in Alzheimer's disease (AD). However, the involvement of zinc in amyloid precursor protein (APP) processing and Aβ deposition has not been well established...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chun-Yan, Wang, Tao, Zheng, Wei, Zhao, Bao-Lu, Danscher, Gorm, Chen, Yu-Hua, Wang, Zhan-You
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003690/ https://www.ncbi.nlm.nih.gov/pubmed/21179415 http://dx.doi.org/10.1371/journal.pone.0015349

Ejemplares similares

Catalpol Inhibits Amyloid-β Generation Through Promoting α-Cleavage of APP in Swedish Mutant APP Overexpressed N2a Cells
por: Wang, Zhuo, et al.
Publicado: (2018)

Facilitation of glutamate, but not GABA, release in Familial Alzheimer's APP mutant Knock‐in rats with increased β‐cleavage of APP
por: Tambini, Marc D., et al.
Publicado: (2019)

Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer’s mice
por: Li, Song, et al.
Publicado: (2015)

Chemical Blocking of Zinc Ions in CNS Increases Neuronal Damage Following Traumatic Brain Injury (TBI) in Mice
por: Doering, Peter, et al.
Publicado: (2010)

Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice
por: Steffen, Johannes, et al.
Publicado: (2017)

Neuronal Rubicon Represses Extracellular APP/Amyloid β Deposition in Alzheimer’s Disease
por: Espinoza, Sandra, et al.
Publicado: (2022)

nanoGold and µGold inhibit autoimmune inflammation: a review
por: Danscher, Gorm, et al.
Publicado: (2023)

NGF controls APP cleavage by downregulating APP phosphorylation at Thr668: relevance for Alzheimer's disease
por: Triaca, Viviana, et al.
Publicado: (2016)

CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage
por: Sun, Jichao, et al.
Publicado: (2019)

Neuroinflammation and Neuronal Loss Precede Aβ Plaque Deposition in the hAPP-J20 Mouse Model of Alzheimer’s Disease
por: Wright, Amanda L., et al.
Publicado: (2013)

Involvement of Receptor Tyrosine Kinase Tyro3 in Amyloidogenic APP Processing and β-Amyloid Deposition in Alzheimer's Disease Models
por: Zheng, Yan, et al.
Publicado: (2012)

Specific antibody binding to the APP(672–699) region shifts APP processing from α- to β-cleavage
por: Li, S, et al.
Publicado: (2014)

The Potential Roles of Exosomes Carrying APP and Tau Cleavage Products in Alzheimer’s Disease
por: Zhao, Yanfang, et al.
Publicado: (2023)

Beneficial Effect of Antibodies against β- Secretase Cleavage Site of App on Alzheimer’s-Like Pathology in Triple-Transgenic Mice
por: Rabinovich-Nikitin, Inna, et al.
Publicado: (2012)

Glial S100A6 Degrades β-amyloid Aggregation through Targeting Competition with Zinc Ions
por: Tian, Zhi-Ying, et al.
Publicado: (2019)

Progranulin Protects against Amyloid β Deposition and Toxicity in Alzheimer’s Disease Mouse Models
por: Minami, S. Sakura, et al.
Publicado: (2014)

Neuronal loss and microgliosis are restricted to the core of Aβ deposits in mouse models of Alzheimer's disease
por: Zhang, Jing, et al.
Publicado: (2021)

Acetylcholinesterase blocks cleavage of APP by γ-secretase in 293 cells and mouse brain
por: Niu, Xin, et al.
Publicado: (2012)

Dampened Slow Oscillation Connectivity Anticipates Amyloid Deposition in the PS2APP Mouse Model of Alzheimer’s Disease
por: Leparulo, Alessandro, et al.
Publicado: (2019)

Biodistribution of gold nanoparticles in mouse lung following intratracheal instillation
por: Sadauskas, Evaldas, et al.
Publicado: (2009)

TRPC6 specifically interacts with APP to inhibit its cleavage by γ-secretase and reduce Aβ production
por: Wang, Junfeng, et al.
Publicado: (2015)

Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APP(SWE)/PS1dE9 Mouse Model of Alzheimer’s Disease Pathology
por: Reale, Marcella, et al.
Publicado: (2018)

Distribution of Copper, Iron, and Zinc in the Retina, Hippocampus, and Cortex of the Transgenic APP/PS1 Mouse Model of Alzheimer’s Disease
por: Hosseinpour Mashkani, Seyed Mostafa, et al.
Publicado: (2023)

A Novel hAPP/htau Mouse Model of Alzheimer's Disease: Inclusion of APP With Tau Exacerbates Behavioral Deficits and Zinc Administration Heightens Tangle Pathology
por: Lippi, Stephen L. P., et al.
Publicado: (2018)

Icariin Decreases the Expression of APP and BACE-1 and Reduces the β-amyloid Burden in an APP Transgenic Mouse Model of Alzheimer's Disease
por: Zhang, Lan, et al.
Publicado: (2014)

Preferential Regulation of Γ‐Secretase‐Mediated Cleavage of APP by Ganglioside GM1 Reveals a Potential Therapeutic Target for Alzheimer's Disease
por: Wang, Xiaotong, et al.
Publicado: (2023)

Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the App(NL−F/NL−F) knock-in mouse model of Alzheimer’s disease
por: Andersson, Emelie, et al.
Publicado: (2023)

New thiazolidinones reduce iron overload in mouse models of hereditary hemochromatosis and β-thalassemia
por: Liu, Jing, et al.
Publicado: (2019)

Increased H-Bond Stability Relates to Altered ε-Cleavage Efficiency and Aβ Levels in the I45T Familial Alzheimer’s Disease Mutant of APP
por: Götz, Alexander, et al.
Publicado: (2019)

Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer’s disease
por: Serneels, Lutgarde, et al.
Publicado: (2020)

APP mouse models for Alzheimer's disease preclinical studies
por: Sasaguri, Hiroki, et al.
Publicado: (2017)

Physiological Mouse Brain Aβ Levels Are Not Related to the Phosphorylation State of Threonine-668 of Alzheimer's APP
por: Sano, Yoshitake, et al.
Publicado: (2006)

Selectivity to amyloid-β precursor protein cleavage provides hope against Alzheimer's
por: Tomita, Taisuke, et al.
Publicado: (2011)

Aggregate-Depleted Brain Fails to Induce Aβ Deposition in a Mouse Model of Alzheimer's Disease
por: Duran-Aniotz, Claudia, et al.
Publicado: (2014)

An Over Expression APP Model for Anti-Alzheimer Disease Drug Screening Created by Zinc Finger Nuclease Technology
por: Zhang, Xiaojing, et al.
Publicado: (2013)

APP intracellular domain derived from amyloidogenic β- and γ-secretase cleavage regulates neprilysin expression
por: Grimm, Marcus O. W., et al.
Publicado: (2015)

Hippocampal functional connectivity across age in an App knock-in mouse model of Alzheimer's disease
por: Morrissey, Zachery D., et al.
Publicado: (2023)

SRC-1 Knockout Exerts No Effect on Amyloid β Deposition in APP/PS1 Mice
por: Wu, Qiong, et al.
Publicado: (2020)

Reduced β-amyloid pathology in an APP transgenic mouse model of Alzheimer’s disease lacking functional B and T cells
por: Späni, Claudia, et al.
Publicado: (2015)

Klotho overexpression improves amyloid‐β clearance and cognition in the APP/PS1 mouse model of Alzheimer's disease
por: Zhao, Yue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aa47fj48sq75onjhkpg8s882ld